Morgan State University Takes Next Step to Add $150M Science Center to Baltimore Campus

5 Questions With Adaptive Phage Therapeutics American Gene Technologies antigen-specific T cells Astek Diagnostics AstraZeneca ATCC atccbiohealth-capital-region BioBuzz Awards BioHealth Capital Region biohealth-capital-regioncovid19 biohealth-capital-regioncovid19novavax biohealth-capital-regionfunding biohealth-capital-regionphiladelphia biohealth-capital-regionregenxbio biohealth-capital-regiontedco BioNTech bioprocessing BioTrain Capital Projects CAR-T Caring Cross CASI Pharmaceuticals Charles River Laboratories Childrens National Hospital clinical-stage biotechnology Coronavirus COVID19 Delfi Diagnostics diversity Emergent BioSolutions FITCI Gain Therapeutics Gene Therapy George Mason University Gilead Sciences HIV I-Mab Intellectual Property JLABS Johns Hopkins University KAPAL Kite Pharma Maryland Maryland Department of Commerce Maryland Stem Cell Research Fund Maryland Tech Council Maxcyte Maxim Biomedical MaximBio Mcbee Moore and Vanik Medimmune Merck NeoImmuneTech NexImmune Novavax People On The Move PQE Group Press Release Qiagen REGENXBIO regionmorgan Sirnaomics state Technology TEDCO Tonix Pharmaceuticals United States Pharmacopeia United Therapeutics university University of Maryland Baltimore Vaccine Vaccines Viela Bio Vigene Biosciences VLP Therapeutics Women In Bio Workforce Genetics